From collection to confidence: why clinical trial data reliability starts early - Pharmaceutical Technology

Reliable clinical trial data starts in Phase 1. Learn how early quality signals protect safety and guide confident sponsor decisions. In early-phase research, reliable data can determine whether a programme advances, stalls or stops. Sponsors need quality signals they can act on. Reliable clinical trial data starts in Phase 1 and is built into study design, risk-based quality management, monitoring, and CAPA. Credit: Shutterstock Every sponsor decision, from dose selection to portfolio prioritisation, depends on whether the evidence generated in a trial is based on reliable data. If data confidence is low, uncertainty can make patient safety oversight harder, slow…

Source: Pharmaceutical Technology